Search

everythinglearnresearchcommunity

for

Search:↓

Combining psychodermatology and PRP therapy can improve skin condition treatment by addressing both mental and physical health.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Exosomes may improve hair growth, but more research is needed for safety and approval.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Various treatments exist for hair loss, but more research is needed for better options.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

PRP and LLLT can improve hair growth in AGA, but more research needed.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

High TNF-α levels may increase hair loss risk after PRP therapy.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Some drugs can cause permanent hair loss, though it's rare.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

A testosterone-induced hair loss model in mice was successfully created for future research and treatment testing.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.